Related Experiment Video
Updated: Jun 2, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Resource and outcome in paediatric diabetes services
Katie L Harron1, Patricia A McKinney, Richard G Feltbower
1Paediatric Epidemiology Group, University of Leeds, Clarendon Way, Leeds LS2 9JT, UK.
Archives of Disease in Childhood
|May 11, 2011
Summary
Resource levels in UK pediatric diabetes services did not correlate with patient glycemic control (mean HbA1c). Despite unmet guidelines, staffing and services didn't directly impact outcomes for children and young people with diabetes.
Area of Science:
- Pediatric Endocrinology
- Health Services Research
- Diabetes Management
Background:
- Paediatric diabetes services in the UK face resource challenges.
- National Institute for Health and Clinical Excellence guidelines recommend specific resource levels.
- Previous research has explored factors influencing pediatric diabetes outcomes.
Purpose of the Study:
- To investigate the association between resource availability and glycaemic control in pediatric diabetes services.
- To analyze the relationship between staffing, services, and clinical outcomes for young people with diabetes.
- To identify if resource levels explain variations in glycaemic control across services.
Main Methods:
- Survey of resource availability (staffing, services) across 21 UK paediatric diabetes services.
- Analysis of demographic and clinical data for 2683 children and young people with diabetes (0-23 years).
- Application of multilevel modelling and graphical techniques to assess resource-outcome relationships, controlling for deprivation, age, and diabetes duration.
Main Results:
- No surveyed service met all recommended resource guidelines.
- No direct association was found between the level of resources and glycaemic control (mean HbA1c).
- Transitional care, nurse caseloads, and specialist access were identified as under-resourced areas, yet did not explain outcome variations.
Conclusions:
- Resource availability alone does not directly determine glycaemic control in paediatric diabetes care.
- Despite identified resource gaps, variations in patient outcomes between services are not solely attributable to resource levels.
- Further research is needed to understand the complex factors influencing paediatric diabetes management and outcomes.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...